Page last updated: 2024-12-08

cdri 81-470

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID146439
CHEMBL ID1797126
MeSH IDM0128180

Synonyms (14)

Synonym
compound 81-470
methyl n-[6-[(4-pyridin-2-ylpiperazine-1-carbonyl)amino]-1h-benzimidazol-2-yl]carbamate
carbamic acid, (5-(((4-(2-pyridinyl)-1-piperazinyl)carbonyl)amino)-1h-benzimidazol-2-yl)-, methyl ester
5(6)-(4-(2-pyridylpiperazino)carbamoyl)benzimidazole-2-carbamate methyl ester
cdri 81-470
93522-20-4
methyl 5(6)-4-2-pyridyl piperazino carbamoyl benzimidazole-2-carbamate
CHEMBL1797126
DTXSID10239465
n-[6-[[4-(2-pyridinyl)-1-piperazinyl]carbonyl]-1h-benzimidazol-2-yl]carbamic acid methyl ester
methyl n-[6-[[4-(2-pyridinyl)-1-piperazinyl]carbonyl]-1h-benzimidazol-2-yl]carbamate
2FR6X7M28E
carbamic acid, n-[6-[[4-(2-pyridinyl)-1-piperazinyl]carbonyl]-1h-benzimidazol-2-yl]-, methyl ester
carbamic acid, [5-[[4-(2-pyridinyl)-1-piperazinyl]carbonyl]-1h-benzimidazol-2-yl]-, methyl ester

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" The oral dose, to the contrary, was poorly absorbed and more than 62."( Metabolic disposition of methyl [5-[[4-(2-pyridinyl)-1-piperazinyl] carbonyl]-1-H-benzimidazol-2-yl] carbamate in hamsters: a study to understand chemoprophylactic action against experimental Ancylostomiasis.
Gupta, S; Katiyar, JC; Singh, SP; Srivastava, JK; Srivastava, VM, 1994
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID603956In-vivo serum to lung partition coefficients of the compound, logP(lung) in rat2008European journal of medicinal chemistry, Mar, Volume: 43, Issue:3
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (36.84)18.7374
1990's10 (52.63)18.2507
2000's2 (10.53)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]